Comment se pose la question du surdiagnostic dans le cancer du sein aujourd’hui ?
Patrice TAROUEL
Radiologue, Montpellier, France – Co-Président du BCU
Where do we stand in developing radionuclides against molecular markers overexpressed on breast cancer (BC) cells such as EGFR-family members?
Willy Wangu
nuclear medicine, Johannesburg, South Africa
Thoughts on DESTINY-Breast04 for HER2-low metastatic breast cancer.
Joseph GLIGOROV
Oncologist, Paris, France
Premalignant lesions: When to avoid open surgery?
Foucauld CHAMMING’S
Conjugated antibodies.
Joseph GLIGOROV
Oncologist, Paris, France